Three participants have died in clinical trials of Novartis' chimeric antigen receptor T-cell therapy for autoimmune disease, prompting physicians to approach patient discussions with greater caution as the field remains in early stages of development.
Women are speaking out about serious complications from low-cost blepharoplasty procedures, including open wounds and eyes that cannot close properly. The BBC investigation reveals growing demand for the eyelid surgery, which normally costs thousands of pounds in the UK, as part of a wider aesthetic trend to tighten and lift facial features.
A public inquiry into serial killer nurse Lucy Letby concluded that her murders of seven babies and attempted murders of seven others at Countess of Chester Hospital could have been prevented, citing failures by hospital management to act on concerns raised by clinicians.
Oli Coppock, 32, suffered catastrophic brain damage after Warrington Hospital's emergency department failed to properly assess his symptoms in May 2024, months after he had received treatment for a brain tumour. His father says the A&E 'did not get the basics right,' leaving his son's life ruined.
Thirty-eight doctors at Dora Nginza Hospital in Gqeberha, South Africa have issued a collective warning that conditions in their obstetrics and gynaecology department pose an 'unacceptable risk' to mothers and babies. Their letter details failing electrical infrastructure, broken resuscitation equipment, and staff shortages following a maternal death.
NHS watchdog has warned that AI technology used to transcribe doctor-patient consultations is putting patients at risk by incorrectly recording drug names and diagnoses. In one case, a patient was wrongly told they had demyelination after an AI scribe misread a 'null demyelination' test result.
Spanish pharmaceutical company Grifols has temporarily halted plasma donations at all 16 of its Canadian clinics following the deaths of two donors and a government investigation into potential unsafe practices at the for-profit facilities.
The U.S. Department of Health and Human Services announced it will decertify Network for Hope, a Kentucky-based organ procurement organization, following allegations that staff continued with organ retrieval procedures despite patients showing signs of life, including a case where a patient was thrashing, crying, and shaking his head.
Becton Dickinson is recalling certain lots of intraosseous vascular access system needle sets following reports of four deaths and multiple injuries. The FDA issued an early alert warning that needle components may lock during insertion, potentially delaying critical care.
Poison control centers have experienced a sharp increase in calls related to semaglutide medications (Ozempic and Wegovy) following their approval for weight management, with researchers finding most cases stem from preventable dosing mistakes such as daily instead of weekly injections or confusion about proper dosage units.
The Philadelphia Department of Public Health recommended patients at a Rittenhouse Square dental office get tested for Hepatitis B, Hepatitis C, and HIV after the office's license was suspended due to infection control violations.
The U.S. Food and Drug Administration has rejected a proposal to reduce regulatory oversight of AI-powered medical devices, highlighting growing policy tension between promoting innovation and ensuring patient safety as AI adoption accelerates in healthcare.
A landmark trial presented at ESCMID Global 2026 demonstrates that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia by 60%, offering a simple intervention to prevent a serious complication.
